Insmed INSM Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $305.96M+230% | $263.84M+153% | $142.34M+52.4% | $107.42M+18.9% | $92.82M+22.9% | ||
| $47.42M+123% | $44.22M+69.1% | $29.37M+38.7% | $28.08M+33.9% | $21.28M+21.9% | ||
| $209.49M+37.3% | $254.91M+41.8% | $186.42M+23.6% | $177.19M+20.7% | $152.58M+26.0% | ||
| $247.26M+67.6% | $212.48M+49.1% | $186.38M+56.7% | $154.76M+45.2% | $147.55M+58.5% | ||
| $459.28M+34.7% | $583.59M+74.3% | $508.35M+65.7% | $420.29M+10.8% | $340.96M+54.3% | ||
| -$153.32M+38.2% | -$319.75M-38.8% | -$366.01M-71.5% | -$312.88M-8.3% | -$248.14M-70.5% | ||
| -50.1%+217pp | -121.2%+99.4pp | -257.1%-28.7pp | -291.3%+28.5pp | -267.3%-74.6pp | ||
| $20.08M-6.9% | $20.6M-4.4% | $20.38M-3.2% | $21.25M-0.1% | $21.57M+2.5% | ||
| -$736K-658% | -$1.82M— | -$603K-133% | $453K+268% | $132K+112% | ||
| -$162.1M+36.6% | -$326.93M-39.5% | -$368.7M-68.0% | -$320.44M-6.9% | -$255.67M-63.4% | ||
| $1.47M+60.6% | $1.55M+22.5% | $1.32M+30.2% | $1.24M+48.3% | $912K+54.8% | ||
| -$163.56M+36.3% | -$328.49M-39.5% | -$370.02M-67.8% | -$321.69M-7.0% | -$256.58M-63.3% | ||
| -53.5%+223pp | -124.5%+101pp | -260%-23.9pp | -299.5%+33.3pp | -276.4%-68.4pp | ||
| -$0.76+46.5% | -$1.53-17.7% | -$1.75-37.8% | -$1.70+12.4% | -$1.42-34.0% | ||
| -$148.31M+39.5% | -$314.19M-38.0% | -$362.01M-71.8% | -$309.13M-8.0% | -$244.99M-71.7% | ||
| -48.5%+215pp | -119.1%+98.9pp | -254.3%-28.8pp | -287.8%+29.0pp | -263.9%-75.0pp | ||
| -$153.32M+38.2% | -$319.75M-38.8% | -$366.01M-71.5% | -$312.88M-8.3% | -$248.14M-70.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Insmed's revenue?
- Insmed (INSM) generated $819.6M in revenue over the trailing twelve months, up 115.1% year over year.
- Is Insmed profitable?
- Insmed is not currently profitable: it reported a net loss of $1.2B over the trailing twelve months, a -144.4% net margin.
- What are Insmed's profit margins?
- Gross margin is 81.8% and operating margin is -140.6%, with a -144.4% net margin.
- What is Insmed's earnings per share?
- Insmed's diluted EPS over the trailing twelve months is $-5.74.
- Where does Insmed's income statement data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
